Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F

被引:358
作者
Brennan, P
Babbage, JW
Burgering, BMT
Groner, B
Reif, K
Cantrell, DA
机构
[1] UNIV UTRECHT, PHYSIOL CHEM LAB, NL-3548 CG UTRECHT, NETHERLANDS
[2] UNIV FREIBURG, TUMOR BIOL CTR, INST EXPT CANC RES, D-79106 FREIBURG, GERMANY
[3] UNIV FREIBURG, DEPT BIOL, D-79106 FREIBURG, GERMANY
关键词
D O I
10.1016/S1074-7613(00)80388-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell cycle progression initiated by interleukin-2 (IL-2) in T cells is critical for lymphoproliferation and an immune response. Phosphatidyl inositol 3-kinase (PI3K) is activated by IL-2. However, nuclear targets for PI3K are not known. Here we identify the cell cycle regulator E2F as an IL-2 target in T lymphocytes and PI3K as the critical signaling pathway. We eliminate both Stat5 and Raf/MEK pathways from E2F regulation. Protein kinase B (PKB) is activated by IL-2 via PI3K. The expression of an active PKB is sufficient to induce E2F activity. Inhibition of PI3K inhibits phosphorylation of Rb, induction of cyclin D3, and degradation of p27(kip1). These results establish a crucial PI3K/PKB-mediated link between the IL-2 receptor and the cell cycle machinery.
引用
收藏
页码:679 / 689
页数:11
相关论文
共 63 条
  • [1] Immunopharmacology of rapamycin
    Abraham, RT
    Wiederrecht, GJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 483 - 510
  • [2] Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
    Ahmed, NN
    Grimes, HL
    Bellacosa, A
    Chan, TO
    Tsichlis, PN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3627 - 3632
  • [3] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [4] The retinoblastoma protein pathway and the restriction point
    Bartek, J
    Bartkova, J
    Lukas, J
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) : 805 - 814
  • [5] Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway
    Beadling, C
    Ng, J
    Babbage, JW
    Cantrell, DA
    [J]. EMBO JOURNAL, 1996, 15 (08) : 1902 - 1913
  • [6] ACTIVATION OF JAK KINASES AND STAT PROTEINS BY INTERLEUKIN-2 AND INTERFERON-ALPHA, BUT NOT THE T-CELL ANTIGEN RECEPTOR, IN HUMAN T-LYMPHOCYTES
    BEADLING, C
    GUSCHIN, D
    WITTHUHN, BA
    ZIEMIECKI, A
    IHLE, JN
    KERR, IM
    CANTRELL, DA
    [J]. EMBO JOURNAL, 1994, 13 (23) : 5605 - 5615
  • [7] Botz J, 1996, MOL CELL BIOL, V16, P3401
  • [8] PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION
    BURGERING, BMT
    COFFER, PJ
    [J]. NATURE, 1995, 376 (6541) : 599 - 602
  • [9] CELL-CYCLE ANALYSIS OF E2F IN PRIMARY HUMAN T-CELLS REVEALS NOVEL E2F COMPLEXES AND BIOCHEMICALLY DISTINCT FORMS OF FREE E2F
    CHITTENDEN, T
    LIVINGSTON, DM
    DECAPRIO, JA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 3975 - 3983
  • [10] The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis
    Corcoran, AE
    Smart, FM
    Cowling, RJ
    Crompton, T
    Owen, MJ
    Venkitaraman, AR
    [J]. EMBO JOURNAL, 1996, 15 (08) : 1924 - 1932